|
Este Boletín comenzó a editarse en 2006 en formato digital y continuará siendo distribuído mensualmente a la lista de suscriptos en fiebre aftosa y enfermedades vesiculares, para mantener la diseminación selectiva de la información escogida por sus suscriptores, a quienes solicitamos actualizar sus datos en "Change your subscription" al pie. Para quienes estén interesados en recibir el Boletín de PANAFTOSA de los restantes temas, ir a la Web de PANAFTOSA y suscribirse colocando nombre e email (columna de la izquierda, debajo del título "Boletín Electrónico"). |
|
Estomatitis Vesicular / Vesicular Stomatitis
 Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates. Mire CE, Miller AD, Carville A, Westmoreland SV, Geisbert JB, Mansfield KG, Feldmann H, Hensley LE, Geisbert TW. PLoS Negl Trop Dis. 2012 Mar;6(3):e1567
Fiebre Aftosa / Foot-and-Mouth Disease
 Emergence of antigenic variants with in serotype A foot and mouth disease virus in India and evaluation of a new vaccine candidate panel. Rudreshappa AG, Sanyal A, Mohapatra JK, Subramaniam S, De A, Das B, Singanallur NB, Jangam AK, Muthukrishnan M, Villuppanoor SA, Pattnaik B.Vet Microbiol. 2012 Mar
 Inclusion of a specific T cell epitope increases the protection conferred against foot-and-mouth disease virus in pigs by a linear peptide containing an immunodominant B cell site. Cubillos C, de la Torre BG, Bárcena J, Andreu D, Sobrino F, Blanco E. Virol J. 2012 Mar 14;9:66
 Upconversion nanoparticles modified with aminosilanes as carriers of DNA vaccine for foot-and-mouth disease. Guo H, Hao R, Qian H, Sun S, Sun D, Yin H, Liu Z, Liu X. Appl Microbiol Biotechnol. 2012 Apr
 Xenoepitope substitution avoids deceptive imprinting and broadens the immune response to foot-and-mouth disease virus. Szczepanek SM, Barrette RW, Rood D, Alejo D, Silbart LK. Clin Vaccine Immunol. 2012 Apr; 19 (4):461-7
Enfermedades Confundidas con Enfermedades Vesiculares / Confused Illnesses with Vesicular Diseases
 Bluetongue sentinel surveillance program and cross-sectional serological survey in cattle in Belgium in 2010-2011. Vangeel I, De Leeuw I, Méroc E, Vandenbussche F, Riocreux F, Hooyberghs J, Raemaekers M, Houdart P, Van der Stede Y, De Clercq K. Prev Vet Med. 2012 Apr
 Development of a highly sensitive gold nanoparticle probe-based assay for bluetongue virus detection. Yin HQ, Jia MX, Yang S, Jing PP, Wang R, Zhang JG. J Virol Methods. 2012 Mar
 Modelling bluetongue virus transmission between farms using animal and vector movements. Turner J, Bowers RG, Baylis M. Sci Rep. 2012;2:319
 Network modeling of BVD transmission. Tinsley M, Lewis FI, Brülisauer F. Vet Res. 2012 Feb 10;43(1):11
Pathogenicity characterization of a bovine triple reassortant rotavirus in calves and piglets. Kim HJ, Park JG, Alfajaro MM, Kim DS, Hosmillo M, Son KY, Lee JH, Bae YC, Park SI, Kang MI, Cho KO. Vet Microbiol. 2012 Mar
 Rescue of recent virulent and avirulent field strains of bluetongue virus by reverse genetics.van Gennip RG, van de Water SG, Potgieter CA, Wright IM, Veldman D, van Rijn PA. PLoS One. 2012;7(2):e30540
Destacados
 La 39a REUNIÓN ORDINARIA de la Comisión Sudamericana para la Lucha contra la Fiebre Aftosa (COSALFA) será realizada en la ciudad de Asunción, Paraguay, en la fecha de 10 y 11 de mayo de 2012
 RIO+20 United Nations Conference on Sustainable Development
 Newsletters PROSAIA
|
